Configure injection-support kits around an approved delivery-system requirement and a controlled bill of materials. Tonmit supports component review, BOM development, packaging and labeling coordination, assembly planning, documentation review and recurring supply for qualified pharmacy, clinic and distributor programs.
Injection-support supplies only. Prescription medication or drug product is not treated as a default kit component on this page.
Built around an approved project brief
Exact component SKU and units per kit
Box · tray · pouch · insert · labels
MOQ, lead time, case pack and availability
Need individual GLP-1 injection supplies rather than an assembled kit? Review Tonmit’s broader program for component-level sourcing, documentation and replenishment.
Review Broader GLP-1 Supply ProgramDo not begin with a generic “GLP-1 starter kit” checklist. Start with the approved presentation or delivery-system requirement, identify only the ancillary items required by the program, then freeze each component, quantity, packaging rule and substitution condition in the BOM.
Prescription medication or drug product is not treated as a default kit component. Medication-related or drug-device combination projects require a separately defined scope and applicable sourcing, handling and documentation review.
| Kit Element | Potential Configuration | Primary Procurement Control |
|---|---|---|
| Delivery-System Review | Pen requiring an external needle, integrated injector, vial-based workflow or other approved presentation | Confirm the exact product presentation and current instructions before selecting ancillary injection supplies |
| Pen Needle / Syringe | Included only when required by the selected delivery workflow | Exact SKU, gauge, length, capacity / scale where applicable, compatibility, sterile barrier and pack count |
| Alcohol Prep Pad | Selected individually wrapped pad options | Exact labeled concentration, pad material / dimensions, sterile status if claimed, pouch and units per box |
| Bandage / Adhesive Item | Optional standard or project-specific format | Size, material, adhesive, sterile status if applicable, individual packaging and quantity |
| Sharps Disposal | Selected compact or point-of-use container format | Capacity, opening, closure, label / waste stream, fill control and exact container SKU |
| Kit Packaging | Box, tray, insert, pouch, instruction card or label set | Approved BOM, component positions, artwork, labeling, lot / expiry treatment where applicable and pack hierarchy |
| Commercial Configuration | Pre-assembled kit, component bundle or bulk component supply | MOQ, units/kit, kits/case, lead time, substitution rules and replenishment schedule |
| Documentation | Component-specific product and packaging records | Match documentation to the exact manufacturer, SKU, label version, target market and transaction |
Some injectable products use an external pen needle, while other presentations use an integrated needle or follow a different supply workflow. The RFQ should begin with the exact program-approved presentation rather than assuming the same needle, syringe or accessory set for every project.
The categories below are procurement options, not a fixed kit recipe. Each selected item must be tied to a defined purpose, exact SKU, quantity per kit, pack hierarchy and approved substitution rule.
Confirm whether the selected presentation requires an external pen needle, syringe or no separate needle at all. Do not infer compatibility from appearance or the GLP-1 category alone.
Review Supply Checklist →
Review labeled concentration, pad size and material, pouch integrity, sterile / nonsterile status where applicable, shelf life and box / case hierarchy for the exact selected SKU.
View Alcohol Prep Pads →
These are optional kit components rather than universal injection requirements. Confirm the required format, dimensions, material, packaging and labeling according to the project specification.
Match the container to the complete post-use sharp, opening, closure, fill line, label / waste stream and use setting rather than adding a generic container solely by nominal capacity.
View Sharps Containers →
Configure the box, tray, component positions, instruction material, outer labels and carton hierarchy after the controlled BOM and pack quantities are approved.
Packaging & Labeling →
Additional items can be reviewed when they have a defined role in the program. Keep conditional products outside the approved core BOM until their SKU, purpose, quantity and packaging are confirmed.
View Diabetes Accessories →A kit name is not a controlled purchase specification. Freeze every component SKU and quantity first, then approve packaging, artwork, case hierarchy, documentation, substitution rules and replenishment.
State the exact device / presentation and define whether the project covers ancillary supplies only or another separately reviewed scope.
Lock each item code, specification, units per kit and approved substitution rule.
Confirm tray / pouch / box layout, artwork, labeling, instruction material and outer-carton hierarchy.
Match records to each SKU and confirm MOQ, lead time, stock route, case pack and repeat-order requirements.
This page covers B2B injection-support components and kit assembly. It does not prescribe a needle, syringe, injection frequency, dose or patient-specific kit. Clinical inputs must come from the applicable medication / device instructions and the buyer’s professional or institutional process.
The workflow separates project definition, BOM control, packaging approval and assembly verification so repeat orders can reference an approved configuration instead of restarting from a generic kit request.
Define delivery system, required components, units per kit, volume, destination and packaging requirements.
Reconcile component SKUs, documents, pack hierarchy, supply path and substitution constraints.
Lock component SKUs, quantities, pack hierarchy and approved substitutions before packaging approval.
Review packaging format, component layout, artwork, labels and insert requirements.
Approve the applicable sample, documented exceptions, revisions and case configuration.
Check component identity, quantity, applicable lot / expiry fields, package condition and label revision.
Confirm kit identity, case pack, shipping quantity, destination and available records.
Repeat orders reference the approved BOM and packaging revision; changes return to project review.
Project deliverables should make the approved configuration repeatable and reviewable. Availability of individual records depends on the selected components, packaging structure and project scope.
Component name, manufacturer / supplier reference, exact SKU, quantity per kit and approved substitution status.
Applicable product, packaging and document references matched to the selected components rather than the kit category alone.
Defined box, pouch or tray format with component positions, insert requirements and packaging hierarchy.
Project-approved artwork and label version with revision control for repeat production or replenishment.
Verification points for component identity, quantity, packaging condition, label revision and traceability fields where applicable.
Kits per case, outer-carton hierarchy, selected supply route and approved configuration reference for repeat orders.
A custom-kit project should be supported by records that can be checked against the approved BOM and packaging revision. The examples below show the types of project-control records that can support buyer review; customer-specific records should be used only when a real project exists and disclosure is permitted.
Responsibilities can change with the target market, component type, private-label structure and contractual arrangement. The project brief should document the applicable split before final approval.
Final responsibilities must be confirmed for the selected product, private-label structure, target market and contract. This page does not assign legal or regulatory responsibility for every possible project.
A custom kit does not have one universal MOQ or production lead time. Commercial terms depend on the approved components, component availability, printed packaging, artwork, assembly quantity, destination and fulfillment route.
For initial project review only; quotation, assembly and delivery timing depend on scope.
Depends on component and packaging requirements.
Depends on BOM, artwork, materials, assembly and supply route.
Connect the controlled BOM with packaging, component-level documentation, applicable U.S. inventory review and repeat supply planning without treating category-level availability as kit-level stock.
Review specifications, labels, pack hierarchy and applicable records for each selected component instead of applying one document set to the whole kit.
Documentation Support →Review box, tray, pouch, insert, artwork and label options after the component BOM and pack quantities are approved.
Packaging Support →Selected component inventory can be reviewed by exact SKU, pack quantity, lot information, remaining shelf life and destination. Finished custom-kit stock should not be assumed.
Fulfillment Support →If the requirement includes individual ancillary supplies in addition to assembled kits, use the broader GLP-1 injection-support supply hub for program-level sourcing.
Review GLP-1 Supply Program →Review delivery-system differences, pen-needle and syringe controls, prep pads, sharps disposal, packaging, supplier evidence and RFQ fields before converting a supply list into a controlled kit.
Common B2B questions about scope, BOM control, packaging, assembly, private label, U.S. inventory, commercial terms and project intake.
Depending on the approved project scope, a kit may include selected pen needles or syringes when required by the delivery system, alcohol prep pads, optional bandage or adhesive items, sharps disposal products, instruction material and custom packaging. The final BOM should identify every exact SKU and quantity.
No universal assumption should be made. Some delivery systems use a separate compatible needle, while other injector presentations use an integrated needle or another supply workflow. Confirm the exact presentation and current instructions before adding needles or syringes to the BOM.
No. This page is structured around injection-support components and kit assembly. Prescription medication or drug product is not treated as a default kit component. Medication-related sourcing should be scoped separately with the applicable requirements.
Eligible projects can be reviewed for box, tray, insert, pouch, artwork and labeling customization. Feasibility depends on the approved component BOM, target market, order volume and applicable product-label requirements.
No universal figure is published because the requirement depends on component MOQ, printed packaging, artwork approval, assembly quantity, inventory route and destination. Final MOQ and lead time are confirmed after the BOM and project scope are reviewed.
Selected components may be supported through U.S. inventory and domestic fulfillment, but availability is SKU-specific. A finished custom kit should not be treated as U.S. stock unless the exact approved kit configuration and available inventory have been confirmed for the transaction.
Provide the delivery-system context, required components, units per kit, expected project volume, packaging format, private-label needs, target market, destination, documentation list, desired delivery window and substitution rules.
Tonmit first reviews the project scope and identifies missing BOM, packaging or commercial inputs. Feasible component and supply paths can then be reviewed before final pricing, MOQ and lead time are confirmed. Initial inquiry responses are typically provided within 1–2 business days; project quotation timing depends on scope.
Providing the fields below reduces back-and-forth and helps the team determine the correct BOM, packaging path and commercial review. Include these details in the RFQ requirements field when submitting the inquiry.